What the company does
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and …
What the weekly tape is saying
PFE closed the latest completed week at 22.64 EUR. The 4-week return is 3.9% and the 12-week return is -1.2%. Trend Signal is active, Market Dynamics is -0.83. Setup signature: Balanced read with a 58/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 22.07 EUR
- Vs Trend Line
- 2.6%
- Fair Value
- 22.15 EUR
- Vs Fair Value
- 2.2%
- 52W High
- 24.44 EUR
- 52W Low
- 18.85 EUR
- Drawdown
- -7.3%
- Range Position
- 67.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 37 weeks
- 52W Active Weeks
- 37
- 52W Active Breadth
- 71.2%
- Sector Scope
- DE Healthcare
- Sector Rank
- 25 of 80
- Sector Percentile
- 69.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
DE Healthcare
- Tracked Peers
- 80
- 4W Rank
- 37 of 80
- Avg 1W
- -1.6%
- Avg 4W
- 1.1%
- Trend Breadth
- 32.5%
- Positive MD
- 43.8%
DE Drug Manufacturers - General
- Tracked Peers
- 12
- 4W Rank
- 6 of 12
- Avg 1W
- -0.1%
- Avg 4W
- 3.6%
- Trend Breadth
- 50.0%
- Positive RS
- 83.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.83
- 4W MD Change
- -32.3%
- Relative Strength
- 4.70
- 4W RS Change
- 2.7%
- Expectation
- Undecided
- Probability
- 48.59%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 164.1K
- 13W Average
- 193.0K
- 52W Average
- 242.6K
- Vs 13W
- 0.9x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.5%
- 52W Volatility
- 3.4%
- Upside Weeks
- 29
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 2.4% / -2.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- GER
- Country
- DE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
- Market Cap
- 126.7B
Opportunity signals
- Trend Signal is active with a 37-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 22.64 EUR | 0.0% | 22.07 EUR | 22.15 EUR | -0.83 | 4.70 | 164.1K | On |
| 5 Jun 2026 | 22.64 EUR | 1.8% | 22.01 EUR | 22.20 EUR | -0.94 | 4.36 | 140.5K | On |
| 29 May 2026 | 22.24 EUR | -0.3% | 21.95 EUR | 22.24 EUR | -0.88 | 1.35 | 132.6K | On |
| 22 May 2026 | 22.30 EUR | 2.3% | 21.88 EUR | 22.29 EUR | -0.76 | 2.73 | 176.8K | On |
| 15 May 2026 | 21.80 EUR | -0.6% | 21.81 EUR | 22.33 EUR | -0.63 | 4.58 | 223.6K | On |
| 8 May 2026 | 21.94 EUR | -1.9% | 21.73 EUR | 22.37 EUR | -0.36 | 3.85 | 334.0K | On |
| 1 May 2026 | 22.36 EUR | -0.2% | 21.68 EUR | 22.41 EUR | -0.07 | 6.31 | 236.7K | On |
| 24 Apr 2026 | 22.39 EUR | -1.5% | 21.67 EUR | 22.44 EUR | 0.39 | 7.41 | 150.4K | On |
| 17 Apr 2026 | 22.74 EUR | 0.7% | 21.56 EUR | 22.48 EUR | 0.81 | 6.81 | 129.5K | On |
| 10 Apr 2026 | 22.59 EUR | -6.9% | 21.44 EUR | 22.52 EUR | 1.06 | 10.27 | 230.5K | On |
| 3 Apr 2026 | 24.26 EUR | 4.3% | 21.34 EUR | 22.57 EUR | 1.19 | 22.01 | 178.4K | On |
| 27 Mar 2026 | 23.25 EUR | 1.4% | 21.19 EUR | 22.61 EUR | 1.09 | 21.79 | 191.7K | On |
| 20 Mar 2026 | 22.92 EUR | 0.2% | 21.08 EUR | 22.65 EUR | 1.05 | 19.95 | 219.7K | On |
| 13 Mar 2026 | 22.88 EUR | 2.4% | 21.01 EUR | 22.70 EUR | 1.03 | 14.46 | 221.1K | On |